Our team

Powered by people.
United by purpose.

Ketotic Hypoglycemia International is a global, volunteer-run organization built by the very people who understand the challenges of Ketotic Hypoglycemia from every perspective.

Different backgrounds.
Different expertise.
One shared mission.

Our team brings together parents and caregivers with physicians, healthcare professionals, scientists, researchers, and advocates from around the world, all united by a shared commitment to improving the lives of individuals and families affected by Ketotic Hypoglycemia.

What began as families searching for answers has grown into a patient-led international community helping connect lived experience with scientific expertise.

Familieshelp identify the questions that need to be answered.
Physiciansand healthcare professionals bring clinical knowledge and experience.
Researchershelp transform observations into evidence and discovery.
Togetherwe work to advance understanding of KH, improve education and clinical care, support meaningful research, and ensure that the patient and family voice remains at the center of progress.
Advocate team

Leading KHI

Danielle Drachmann

Danielle Drachmann

Founder and President

Danielle Drachmann is the Founder and President of Ketotic Hypoglycemia International (KHI), a global patient-led organization advancing the understanding, research, recognition, and care of Ketotic Hypoglycemia (KH).

Her leadership is rooted in both lived experience and scientific inquiry. After Danielle and her children were diagnosed with Idiopathic Ketotic Hypoglycemia (IKH), she recognized significant gaps in clinical knowledge, research, and patient support. Rather than accepting those gaps, she built KHI to bring patients, caregivers, physicians, researchers, and healthcare leaders together to help answer questions that had remained largely unexplored for decades.

With a Master’s degree in Anthropology of Health, Danielle has become a leading voice in patient-driven research and rare disease advocacy. She has helped establish a model in which lived experience is transformed into research questions, patient observations inform scientific investigation, and families become active partners in advancing medical knowledge.

Danielle is a published co-author of multiple peer-reviewed scientific publications on Ketotic Hypoglycemia. Her work includes the landmark Orphanet Journal of Rare Diseases publication, “Towards Enhanced Understanding of Idiopathic Ketotic Hypoglycemia,” which helped establish a framework distinguishing physiological from pathological Ketotic Hypoglycemia and formally introduced KHI to the scientific community. She subsequently co-authored research identifying Ketotic Hypoglycemia in individuals with Down syndrome and contributed to “Idiopathic Pathological Ketotic Hypoglycemia: Finding the Needle in a Haystack,” advancing the scientific conversation around severe, recurrent, and unexplained forms of KH.

Her work extends beyond publication. Danielle has contributed to international rare disease policy and patient engagement initiatives, represented patient perspectives within European healthcare discussions, and championed citizen science as a mechanism for accelerating discovery in underrecognized conditions.

Through KHI, Danielle continues to build international collaboration among families, pediatric endocrinologists, metabolic specialists, geneticists, researchers, healthcare institutions, and rare disease partners. Her leadership is helping move Ketotic Hypoglycemia from an often-overlooked clinical presentation toward a field of growing scientific investigation.

Danielle’s vision for KHI is clear: bring patients and science together to ask better questions, generate stronger evidence, improve clinical understanding, and ultimately create better outcomes for every person affected by Ketotic Hypoglycemia.

Amanda Roser

Amanda Roser

Chief Executive Officer (CEO)

Amanda Roser serves as Chief Executive Officer of Ketotic Hypoglycemia International (KHI), working alongside Founder and President Danielle Drachmann to lead the organization’s strategic growth and expand its global impact across research, education, advocacy, and patient support.

Amanda brings more than 18 years of marketing and business leadership experience, with extensive expertise in healthcare and medical device marketing, organizational growth, strategic partnerships, digital strategy, communications, and stakeholder engagement. As Vice President of Marketing and Operations at Social Strategy1, she has led multidisciplinary teams and growth initiatives for healthcare organizations and medical technology companies, providing her with a strong understanding of both the business and clinical healthcare environments.

Her leadership at KHI is also informed by lived experience. Amanda’s son, Christopher, developed severe Ketotic Hypoglycemia as a toddler, beginning a complex diagnostic and medical journey that exposed her firsthand to the challenges families face when navigating an underrecognized metabolic condition.

Amanda initially brought her professional expertise to KHI as a volunteer heading up marketing and has since transitioned into executive leadership. As CEO, she is focused on strengthening KHI’s organizational infrastructure, developing strategic and industry partnerships, expanding scientific and clinical education, increasing global awareness, supporting research collaboration, and creating stronger connections among patients, caregivers, physicians, researchers, healthcare institutions, and industry.

Together with Danielle and KHI’s international network of medical and scientific advisors, Amanda is helping position KHI for its next phase of growth, building a sustainable organization capable of accelerating research, improving clinical understanding, and creating meaningful, measurable impact for individuals and families affected by Ketotic Hypoglycemia worldwide.

Nick Ben

Nick Ben

Head of Marketing

Nick leads KHI’s communication. He ghostwrites the speeches, designs the presentations and prepares Danielle Drachmann for the political and scientific events she speaks at, most recently the European Parliament’s hearing on advanced therapies in November 2026.

He also built this website. In his day job, Nick works in affiliate and partner marketing.

Our advisors

Expertise from around the world

Our organization is strengthened by a global Scientific Advisory Board and Emerging Researchers Board, bringing expertise across pediatric endocrinology, metabolic medicine, glycogen storage diseases, complex hypoglycemia, genetics, and related areas of research.

Get involved

Help us do more

Everything KHI has built so far was built by volunteers, without major funding. Your support helps us keep going.

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.